Johnson & Johnson Completes Purchase Of Israeli Startup V-Wave

Johnson & Johnson has finalized its acquisition of the Israeli medtech company V-Wave, which specializes in devices for treating heart failure. The deal, first announced in August, marks V-Wave’s integration into Johnson & Johnson MedTech, enhancing its portfolio in medical technology.

V-Wave is known for its innovative Ventura Interatrial Shunt (IAS), a minimally invasive treatment that aims to improve outcomes for patients suffering from heart conditions.